{{medical}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 388126663
| IUPAC_name = 7-[(1''R'',3''R'')-3-hydroxy-2-[(1''E'',3''S'')-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid
| image = Alprostadil.svg
| image2 = Alprostadil-BallStick.png

<!--Clinical data-->
| tradename =  
| MedlinePlus = a695022
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  Rx only Canada
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CASNo_Ref = {{cascite}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 745-65-3
| ATC_prefix = C01
| ATC_suffix = EA01
| ATC_supplemental =  {{ATC|G04|BE01}}
| PubChem = 149351
| IUPHAR_ligand = 1882
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
 | DrugBank = DB00770
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 495

<!--Chemical data-->
| C=20 | H=34 | O=5
| molecular_weight = 354.481 g/mol
}}
'''前列腺素E<sub>1</sub>'''（'''Prostaglandin E<sub>1</sub>'''；'''PGE1'''），亦稱'''前列地爾'''（'''Alprostadil'''）<ref name="pmid8527291">{{cite journal |author=Cawello W, Leonhardt A, Schweer H, Seyberth HW, Bonn R, Lomeli AL |title=Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion |journal=British Journal of Clinical Pharmacology |volume=40 |issue=3 |pages=273–6 |date=September 1995 |pmid=8527291 |pmc=1365109 |doi= |url=https://archive.org/details/sim_british-journal-of-clinical-pharmacology_1995-09_40_3/page/273}}</ref> 是一種[[前列腺素|前列腺素]]，常用於治癒[[勃起障礙|勃起障礙]]、<ref name="pmid12494285">{{cite journal |author=Harding LM, Adeniyi A, Everson R, Barker S, Ralph DJ, Baranowski AP |title=Comparison of a needle-free high-pressure injection system with needle-tipped injection of intracavernosal alprostadil for erectile dysfunction |journal=International Journal of Impotence Research |volume=14 |issue=6 |pages=498–501 |date=December 2002 |pmid=12494285 |doi=10.1038/sj.ijir.3900916}}</ref> 進行[[血管舒張|血管舒張]]等。

== 醫學用途 ==

前列地爾在美國主要被當做[[尿道|尿道]][[栓劑|栓劑]]和血管注射劑。栓劑的商標名是MUSE，<ref>{{cite web|title=Muse Suppository - Facts and Comparisons|url=http://www.drugs.com/cdi/muse-suppository.html|publisher=Drugs.com|accessdate=4 January 2013|archive-date=2013-01-19|archive-url=https://web.archive.org/web/20130119131710/http://www.drugs.com/cdi/muse-suppository.html|dead-url=no}}</ref> 血管注射劑則是Edex<ref>[http://www.drugs.com/cdi/edex.html Edex - Facts and Comparisons] {{Wayback|url=http://www.drugs.com/cdi/edex.html |date=20121026073759 }} Drugs.com</ref> 和Caverject。<ref>[http://www.drugs.com/cdi/caverject.html Caverject - Facts and Comparisons] {{Wayback|url=http://www.drugs.com/cdi/caverject.html |date=20121026075757 }} Drugs.com</ref> 前者直接作用於尿道以治療[[陰莖|陰莖]]疾病，後者用途相同，但是方法是通過注射器注射到[[陰莖海綿體|陰莖海綿體]]中而發生作用。

前列地爾可用於治療[[新生兒|新生兒]][[動脈導管未閉|動脈導管未閉]]。有時嚴重肢體缺血也會用到前列地爾，通過舒張血管而達到刺激血管再生。

==參考文獻==
{{reflist}}

{{類花生酸類}}

[[Category:前列腺素类|Category:前列腺素类]]
[[Category:羧酸|Category:羧酸]]
[[Category:勃起功能障礙藥物|Category:勃起功能障礙藥物]]